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Abstract
Introduction: The prognostic value of continuous monitoring of
tissue oxygen saturation (StO2) during early goal-directed therapy
of critically ill patients has not been investigated. We conducted
this prospective study to test the hypothesis that the persistence of
low StO2 levels following intensive care admission is related to
adverse outcome.
Methods: We followed 22 critically ill patients admitted with
increased lactate levels (>3 mmol/l). Near-infrared spectroscopy
(NIRS) was used to measure the thenar eminence StO2 and the rate
of StO2 increase (RincStO2) after a vascular occlusion test. NIRS
dynamic measurements were recorded at intensive care admission
and each 2-hour interval during 8 hours of resuscitation. All repeated
StO2 measurements were further compared with Sequential Organ
Failure Assessment (SOFA), Acute Physiology and Chronic Health
Evaluation (APACHE) II and hemodynamic physiological variables:
heart rate (HR), mean arterial pressure (MAP), central venous oxygen
saturation (ScvO2) and parameters of peripheral circulation (physical
examination and peripheral flow index (PFI)).
Results: Twelve patients were admitted with low StO2 levels (StO2
<70%). The mean scores for SOFA and APACHE II scores were
significantly higher in patients who persisted with low StO2 levels
(n = 10) than in those who exhibited normal StO2 levels (n = 12) at
8 hours after the resuscitation period (P <0.05; median
(interquartile range): SOFA, 8 (7 to 11) vs. 5 (3 to 8); APACHE II,
32 (24 to 33) vs. 19 (15 to 25)). There was no significant
relationship between StO2 and mean global hemodynamic variables
(HR, P = 0.26; MAP, P=0.51; ScvO2, P = 0.11). However, there
was a strong association between StO2 with clinical abnormalities
of peripheral perfusion (P = 0.004), PFI (P = 0.005) and RincStO2
(P = 0.002). The persistence of low StO2 values was associated
with a low percentage of lactate decrease (P <0.05; median
(interquartile range): 33% (12 to 43%) vs. 43% (30 to 54%)).
Conclusions: We found that patients who consistently exhibited
low StO2 levels following an initial resuscitation had significantly
worse organ failure than did patients with normal StO2 values, and
found that StO2 changes had no relationship with global hemo-
dynamic variables.
Introduction
A more complete evaluation of tissue perfusion can be
achieved by adding non-invasive assessment of peripheral
perfusion to global parameters [1]. Non-invasive monitoring of
peripheral perfusion is an alternative approach that allows
very early application throughout the hospital, including the
emergency department, operating room, and hospital wards.
The rationale of monitoring peripheral perfusion is based on
the concept that peripheral tissues are the first to reflect
hypoperfusion in shock and the last to reperfuse during
resuscitation [1,2]. Poor peripheral perfusion may therefore
be considered an early predictor of tissue hypoperfusion and
a warning signal of ongoing shock.
In the clinical practice, non-invasive monitoring of peripheral
perfusion can be performed easily using current new
technologies, such as near-infrared spectroscopy (NIRS) [3].
NIRS technology has been used as a tool to monitor tissue
oxygen saturation (StO2) in acutely ill patients [4]. In addition,
the analysis of changes in StO2 during a vascular occlusion
test, such as a brief episode of forearm ischemia, has been
used as a marker of integrity of the microvasculature – in
particular, the StO2 recovery after the vascular occlusion test
[5-7]. These reports, however, have studied the correlation of
intermittent StO2 measurements and outcome where there
are only limited data describing whether continuous monitor-
ing of StO2 during the early resuscitation phase is related to
morbidity or to mortality.
We therefore conducted the present prospective obser-
vational study to investigate the association between
continuous StO2 measurements during early resuscitation of
high-risk patients and subsequent adverse outcomes. The
primary study objective was to investigate whether persis-
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tence of low StO2 values during early goal-directed therapy
could help to identify patients with more severe organ dys-
function and severity of disease as expressed by Sequential
Organ Failure Assessment (SOFA) and Acute Physiology and
Chronic Health Evaluation (APACHE) II scores. Because the
value of StO2 as a parameter of peripheral perfusion is not
quite clear, we also investigated the relation of low StO2
values with global hemodynamic and peripheral circulation
parameters.
Materials and methods
Study population
The current prospective observational study was conducted
in the intensive care unit (ICU) of a university hospital. We
enrolled 22 consecutive critically ill patients with increased
lactate levels (>3 mmol/l) who had no history of severe peri-
pheral vascular disease. The institutional review board
approved the study. Each patient or relative provided written
informed consent.
Measurements
Global hemodynamic variables included the heart rate (HR),
central venous pressure, mean arterial pressure (MAP) and
central venous oxygen saturation (ScvO2). All measurements
were obtained using standard equipment. ScvO2 was
measured continuously with a fiber-optic probe (CeVOX®;
Pulsion Medical Systems AG, Munich, Germany). Thenar
StO2 was continuously monitored using an InSpectra Tissue
Spectrometer Model 650 (Hutchinson Technology Inc.,
Hutchinson, MN, USA) with a 15 mm probe over the thenar
eminence. Based on the variability of StO2 values in previous
studies, we used a cut-off value of 70% to define the StO2
level as low [5-11].
We measured the StO2 response to the vascular occlusion
test to investigate peripheral perfusion reactivity. The vascular
occlusion test was performed using a sphygmomanometer
cuff wrapped around the arm over the brachial artery. After a
1-minute period to stabilize the NIRS signal, the cuff was
rapidly inflated until 30 mmHg above the systolic arterial
pressure. After 3 minutes of ischemia, the sphygmomano-
meter was rapidly deflated and the StO2 was recorded until
the StO2 level returned to baseline values. The vascular
occlusion test-derived StO2 traces were analyzed for the rate
of StO2 increase (RincStO2) during the release. We
calculated the RincStO2 slope obtained by the regression line
between the lowest StO2 value and the StO2 correspondent
to the baseline value following the ischemic period (slope,
expressed as percent per second). One individual who was
blinded from all treatment and clinical data performed the
NIRS measurements.
Peripheral circulation parameters included physical examina-
tion of peripheral perfusion and the peripheral flow index
(PFI). Based on physical examination of peripheral perfusion,
patients were considered to have abnormal peripheral
perfusion if the examined extremities (both hands) had an
increase in capillary refill time or were cool to the examiner’s
hands. The capillary refill time was measured by applying firm
pressure to the distal phalanx of the index finger for
15 seconds. A chronometer recorded the time for the return
of the normal color and 4.5 seconds was defined as the
upper limit of normality [12]. The PFI provides a non-invasive
method for evaluating perfusion and has been shown to
reflect changes in peripheral perfusion [13,14]. The PFI is
derived from the pulse oximetry signal, which was obtained
from a Nellcor-OxiMax pulse oximeter and Hewlett Packard
monitor (Viridia 56S, Philips Medical Systems, Boblingen,
Germany).
The ICU contains single-person closed rooms, and the
ambient temperature in each patient’s room was individually
and actively set at 22°C.
Study protocol
All patients were followed during the first 8 hours after ICU
admission. Hemodynamic support in all patients – including
vasopressor (noradrenaline) and, if needed, addition of
dobutamine – was aimed at standard resuscitation endpoints
adapted from the Surviving Sepsis Campaign Guidelines to
maintain HR <100/minute, MAP ≥60 mmHg, central venous
pressure of 8 to 12 mmHg, urinary output ≥0.5 ml/kg/hour
and ScvO2 ≥70% [15]. Measurements, obtained continuously
between admission and the 8-hour period of resuscitation,
included temperature, all global hemodynamic variables, StO2,
the PFI and physical examination of peripheral perfusion.
Arterial blood samples were withdrawn simultaneously for
lactate measurement. The vascular occlusion test was
performed at two time points: immediately upon admission to
the ICU and again after 8 hours of resuscitation. Basic
demographic characteristics, APACHE II and SOFA scores
were collected for each patient. Clinical and laboratory data
needed to calculate the SOFA and APACHE II scores were
reported as the worst value within 24 hours after ICU
admission.
Hyperlactatemia was defined as a blood lactate level
>3 mmol/l. We calculated the percentage of lactate decrease
over the first 8-hour period of ICU admission. All patients
were mechanically ventilated and sedation with midazolam
and analgesia was provided according to individual needs.
Statistical analysis
Unless otherwise specified, the results are presented as the
median (interquartile range). Differences between group
means were tested by Student t-tests; for variables that were
not normally distributed, differences were tested by a
nonparametric test. For clinical characteristics of the study
groups, differences between groups were assessed using
Fisher’s exact test. The multiple regression analysis adjusted
for global hemodynamic variables (HR, MAP and central
venous pressure) was used to analyze the impact of thepersistence of StO2 <70% on the SOFA and APACHE II
scores. We used the linear mixed-model analysis to assess
the magnitude of contribution from each systemic and
peripheral physiological variable on all repeated StO2
measurements during the 8-hour period of resuscitation.
P ≤0.05 was considered statistically significant.
Results
Patients’ demographic data are summarized in Table 1. All
data used in the analysis were obtained at 2 hours, 4 hours,
6 hours and 8 hours after admission.
To explore the relationship between changes of StO2 and the
severity of organ dysfunction, we stratified patients according
to the evolution of StO2 levels within the 8-hour period of ICU
resuscitation. Upon ICU admission, 12 (54%) patients had
low StO2 levels. From these 12 patients, two patients
showed normalization of the StO2 levels. All patients admitted
with normal StO2 still had a normal StO2 at 8 hours of
resuscitation. A total of 10 patients therefore persisted with
low StO2 and 12 patients with normal StO2 levels after the
8 hours of ICU resuscitation (Figure 1).
Figure 2 shows the SOFA and APACHE II scores stratified
by the groups after 8 hours of resuscitation. The mean scores
for both SOFA and APACHE II scores were significantly
higher in patients who persisted with low StO2 levels than in
those who exhibited normal StO2 levels 8 hours after the
resuscitation period (P <0.05; median (interquartile range):
APACHE II score, 32 (24 to 33) vs. 19 (15 to 25); SOFA
score, 8 (7 to 11) vs. 5 (3 to 8)) (Figure 2). Multiple
regression analysis on low StO2 levels adjusted for global
hemodynamic variables (HR, MAP and central venous
pressure) showed that low StO2 levels had a significant
contribution for the prediction of SOFA score (regression
coefficient = 3.0, 95% confidence interval = 2.2 to 5.7;
P = 0.04) and APACHE II score (regression coefficient = 9.1,
95% confidence interval = 3.3 to 13; P = 0.026).
The relationship between all repeated StO2 measurements
during the 8-hour period of resuscitation with standard hemo-
dynamic variables and with peripheral circulation parameters
was assessed using the mixed-model analysis to further
explore the contribution from each of these variables on the
StO2 level. Table 2 presents the estimation coefficient from
each variable. There was no significant relationship between
StO2 and global hemodynamic variables. There was a strong
association, however, between StO2 and clinical abnor-
malities of peripheral perfusion, the PFI and RincStO2. Table 3
presents the descriptive analysis of global hemodynamic
variables and peripheral circulation parameters stratified by
the level of StO2 at admission and after 8 hours. In patients
who received vasopressor therapy during resuscitation
(number of patients = 16; number of StO2 measurements =
64), the dose of vasopressor (noradrenaline) did not differ
between low (n = 35) and normal (n = 29) StO2 levels
(P = 0.13; median (interquartile range): 0.19 (0.10 to 0.33)
vs. 0.13 (0.06 to 0.25) μg/kg/minute).
Although there was no difference in admission lactate levels
between patients with low and normal StO2 levels (P = 0.34;
median (interquartile range): 3.6 (2.2 to 6.0) vs. 3.4 (3.0 to
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Table 1
Patient demographic data
Number of patients 22
Age (years) 62 (57 to 71)
Male/female 16/6
Sequential Organ Failure Assessment score 7 (5 to 9)
Acute Physiology and Chronic Health Evaluation II score 23 (16 to 30)
Admission category
Septic shock 3 pneumonia, 3 abdominal sepsis, 1 meningitis
Circulatory failure not associated with sepsis 3 hypovolemic/hemorrhagic, 3 cardiogenic, 4 postoperative, 2 trauma
Without circulatory failure or sepsis 1 cerebrovascular accident, 2 postoperative
Noradrenaline use 16 (72%)
Noradrenaline dose (μg/kg/minute) 0.16 (0.07 to 0.24)
Dobutamine use 8 (36%)
Dobutamine dose (μg/kg/minute) 4.3 (3.6 to 6.3)
Mechanical ventilation 15 (68%)
Survivor/nonsurvivor 17/5
Data expressed as number, as median (25th to 75th percentile), or as n (%).5.0)), the percentage of lactate decrease between admission
and after the 8-hour period of resuscitation was significantly
lower in patients who persisted with low StO2 levels (P
<0.05; median (interquartile range): 33% (12 to 43%) vs.
43% (30 to 54%)). A persistently low StO2 level was
associated with increased mortality. Among the nonsurvivors,
4/5 (80%) patients had persistently low StO2 levels after the
8-hour period of resuscitation – compared with 6/17 (35%)
patients in the survivor group.
Discussion
In the present prospective observational study, we performed
repeated StO2 measurements in critically ill patients to test
the hypothesis that the persistence of low StO2 levels during
the early resuscitation phase of therapy is associated with a
more severe organ dysfunction. The most important finding in
our study is that patients who failed to normalize StO2 during
early treatment in the ICU had more severe organ dysfunction
and disease severity, as assessed by SOFA and APACHE II
scores. The higher SOFA score in our patients with low StO2
levels could have been related to therapeutic interventions
applied guided by global hemodynamic measurements. The
association between low StO2 levels and organ failure in our
patients, however, was not accompanied by any major
differences in either global hemodynamic variables or doses
of vasopressor therapy between patients with low and normal
StO2 levels. In addition, we also found that the APACHE II
score was significantly higher in patients with low StO2
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Figure 1
Evolution of StO2 levels in our patient population stratified by low
(StO2 <70%) and normal (StO2 ≥70%) values upon admission (T0)
and 8 h after resuscitation (T8). ICU, intensive care unit; StO2, tissue
oxygen saturation.
Figure 2
Box plotting demonstrating the outcome score values stratified by the
StO2 levels 8 h after resuscitation: StO2 <70% (n = 10); StO2 ≥70%
(n = 12). APACHE, Acute Physiology and Chronic Health Evaluation;
SOFA, Sequential Organ Failure Assessment; StO2, tissue oxygen
saturation. *Significant, Wilcoxon rank test.levels. The APACHE II score differs from the SOFA score
since the former is not adjusted for the use of vasoactive
drugs. These findings therefore suggest that the presence of
low StO2 levels does not reflect global hemodynamic effects
or vasoconstriction from a pharmacologic intervention.
The association between low StO2 levels and organ failure in
our patients was accompanied by alterations in clinical
abnormalities of peripheral perfusion. Current observations
have shown a significant association between clinical
abnormal peripheral perfusion and severity of organ dys-
function in patients suffering from either septic shock or
nonseptic shock [16-19]. This relationship is supported by
the present study. The association of low StO2 levels with
clinical abnormalities of peripheral perfusion in our patients
may partly explain the relationship between abnormal
peripheral perfusion and a worse outcome. Additionally, low
StO2 levels were also associated with a slow rise in StO2
following a vascular occlusion test. Abnormal RincStO2 levels
have been shown to reflect a variety of dynamic variables
linked to local metabolic demand and vascular reactivity that
have been associated with outcome in critically ill patients
[5-7]. A causal relationship between low StO2 and abnormal
RincStO2 in our patients is not clear, as it was not the topic of
the current study. Furthermore, the association between an
abnormal RincStO2 and low StO2 levels is not always present,
as previous reports have shown a decreased RincStO2 in the
presence of normal StO2 values [5,6]. In our patients,
however, an abnormal RincStO2 and low StO2 values were
associated with a low PFI, indicating either peripheral
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Table 2
Contribution from systemic and peripheral physiological variables on repeated tissue oxygen saturation measurements during
resuscitation
Variable StO2 estimation coefficient (95% confidence interval) P-value Number of observations
Systemic hemodynamic
Heart rate –0.08 (–0.23 to 0.63) 0.26 88
Mean arterial pressure –0.05 (–0.22 to 0.11) 0.51 88
Central venous oxygen saturation 0.11 (–0.13 to 0.36) 0.36 88
Peripheral circulation
Clinical abnormalities 5.7 (2.0 to 9.6) 0.004 88
Peripheral flow index 8.1 (2.3 to 13.1) 0.005 88
RincStO2 3.9 (2.1 to 6.0) 0.002 44
Using the linear mixed-models analysis, we assessed the magnitude of contribution from each systemic and peripheral physiological variable on all
repeated tissue oxygen saturation (StO2) measurements during the 8-hour period of resuscitation. RincStO2, rate of StO2 increase after the
vascular occlusion test.
Table 3
Global hemodynamic variables and peripheral circulation parameters stratified by StO2 level before and after resuscitation
Admission After 8 hours of resuscitation
Low StO2 Normal StO2 Low StO2 Normal StO2
(n = 12) (n = 10) P-value (n = 10) (n = 12) P-value
Heart rate (beats/minute) 94 (79 to 122) 91 (82 to 106) 0.90 95 (79 to 113) 98 (74 to 122) 0.90
Mean arterial blood pressure (mmHg) 77 (64 to 94) 79 (72 to 85) 0.87 67 (60 to 75) 72 (68 to 85) 0.14
Central venous pressure (mmHg) 15 (11 to 18) 12 (9 to 14) 0.20 19 (6 to 20) 15 (7 to 15) 0.34
Central venous oxygen saturation (%) 75 (63 to 79) 73 (68 to 84) 0.38 77 (68 to 85) 70 (65 to 80) 0.46
Peripheral flow index (%) 0.2 (0.2 to 0.7) 1.8 (0.8 to 3.7) 0.001 0.9 (0.4 to 1.1) 2.1 (1.2 to 3.0) 0.004
Clinical abnormalities of peripheral perfusion 11 (92%) 3 (30%) 0.006* 9 (90%) 1 (8%) 0.001*
RincStO2 (%/second) 1.8 (1.4 to 2.0) 4.0 (2.6 to 4.7) 0.001 1.7 (1.2 to 2.5) 4.4 (2.9 to 4.7) 0.003
Global hemodynamic variables and peripheral circulation parameters in patients with low tissue oxygen saturation (StO2; <70%) and normal StO2
(>70%) at admission and after 8 hours of resuscitation. Data expressed as median (25th to 75th percentile) or as n (%). RincStO2, rate of StO2
increase after the vascular occlusion test. *Significant, Fisher’s exact test.vasoconstriction and/or impairment of microcirculatory flow
as indicated by the slowed reperfusion during ischemic
recovery [20].
Although there was no difference in admission lactate levels,
the percentage of lactate decrease during the study was
significantly lower in patients who consistently exhibited low
StO2 values. The interpretation of hyperlactatemia in critically
ill patients is complex, and factors other than hypoperfusion
may be involved [21]. Both hyperlactatemia at admission and
the lack of its reduction during ICU treatment have been
related to increased mortality [22-24]. The correlation
between hyperlactatemia and low StO2 in our patients could
be related to the presence of tissue hypoperfusion
[22,25,26]. Nevertheless, our findings support previous
reports, including our own, showing that patients with clinically
abnormal peripheral perfusion following resuscitation are more
likely to remain hyperlactatemic [19,27].
Regardless of the cause of peripheral tissue hypoperfusion,
our data provide evidence that the persistence of low StO2
values could have implications for the treatment of critically ill
patients. Restoration of global hemodynamic parameters
without an associated normalization of StO2 may warrant
further or intensified resuscitation efforts. As the thenar
muscle StO2 monitoring is safe, non-invasive and easily
obtained at the bedside – enabling the physicians to identify
patients with peripheral tissue hypoperfusion – it may
represent a valuable addition to our monitoring tools and end-
points of goal-directed therapy. The clinical value of repeated
StO2 measurements must be investigated further, however,
to assess whether a resuscitation goal of normalizing StO2
levels will improve patient outcome.
The present study has some limitations that should be
acknowledged. First, previous studies have suggested that
resting StO2 values are insensitive indicators of tissue
perfusion [5-7]. These studies noted that both patients and
healthy control individuals had similar StO2 levels despite
evidence of impaired systemic oxygenation in patients. In
these studies, however, a StO2 threshold as well as a time
factor was not taken into account. In our study, the repeated
measurements of StO2 during early resuscitation were the
prognostic factor, and the persistence of StO2 levels below
the threshold of 70% was associated with the development
of a more severe organ injury. Although the optimal StO2
threshold has not been fully investigated and not yet
determined in critically ill patients, we arbitrarily chose 70%
based on previous studies performed in healthy volunteers
and in emergency and intensive care patients [5-11].
Second, the number of patients included in the present study
was limited. Only two patients changed their StO2 level from
low to normal; therefore, the prognostic value in this particular
group could not be studied. From our findings, however, it is
clear that patients who consistently showed low StO2 values
within the first 8 hours of ICU treatment had a significantly
higher rate of unfavorable outcome. Additionally, the absence
of low StO2 levels identified patients with a more favorable
outcome.
Finally, measurements of global blood flow (cardiac output)
were not made in this study. Our main focus, however, was to
assess the relationship between the presence of a low StO2
level following our standard hemodynamic optimization
protocol and organ dysfunction.
In conclusion, we established the usefulness of the continu-
ous monitoring of StO2 during the early resuscitation of
critically ill patients. We found that patients who retained low
StO2 levels following an initial resuscitation had significantly
worse organ failure than did patients with normal StO2
values. In addition, low StO2 levels were only accompanied
by alterations in the peripheral circulation – indicating that
StO2 abnormalities are closely related to regional hemo-
dynamics rather than macrohemodynamics.
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